Begin main content

Reports

We found 5097 result(s)

rivaroxaban (Xarelto)

Last Updated: June 15, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: rivaroxaban
Indications: Prevention of stroke and cardiovascular events in coronary and peripheral artery disease.

  • Brand Name: Xarelto
  • Manufacturer: Bayer Inc.
  • Project Number: SR0569-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Coronary Artery Disease, Stroke, Cardiovascular, Coronary artery disease, Heart attack, Peripheral vascular disease, Stroke

Health Technology Update — Issue 20

Published on: June 15, 2018
Result type: Reports
Product Line: Health Technology Update
opens in document viewer

This issue of Health Technology Update features brief summaries of information on a broad range of medical technologies — from nature-assisted therapy to emerging obstructive sleep apnea devices. These technologies were identified through CADTH’s Horizon Scanning Service as topics potentially of interest to health care decision-maker...

  • Project Number: EN0010-000

Tags

Diagnostic Tests, Mental Health, PTSD, Shell Shock, Sleep Disorders, Diagnostic tests, Gynecology/obstetrics, Medical devices, Mental health, Musculoskeletal, AVACEN, Aersleep, Bresodx, PneumoLiner, Portable device, Posttraumatic stress, Sleep apnoea, Sommetric, contained tissue extraction, ecotherapy, heat therapies, heat therapy, heat treatment, heat treatments, home sleep test, morcellation, post traumatic stress, power morcellator, prostate enlargement, thermal therapies, thermal treatment, thermal treatments, uterine fibroids, warmth therapies, warmth therapy, warmth treatment, warmth treatments

fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta)

Last Updated: June 14, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluticasone furoate umeclidinium vilanterol
Indications: Chronic obstructive pulmonary disease (COPD)

  • Brand Name: Trelegy Ellipta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0562-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

COPD, COPD, Respiratory

netupitant / palonosetron (Akynzeo)

Last Updated: June 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: netupitant / palonosetron
Indications: Nausea and vomiting (chemotherapy induced) prevention

  • Brand Name: Akynzeo
  • Manufacturer: Purdue Pharma
  • Project Number: SR0548-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Cancer, Digestive System, Cancer, Digestive system, Antiemetic; antiemetics; Nausea; Vomiting; Cancer; Neoplasm; palonosetron; netupitant; Akynzeo

Dolutegravir / rilpivirine (Juluca)

Last Updated: June 14, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dolutegravir rilpivirine
Indications: HIV infection

  • Brand Name: Juluca
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0551-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV, Human Immunodeficiency Virus Proteins, HIV/AIDS, Infectious diseases, HIV; rilpivirine; dolutegravir; Juluca; human immuno-deficiency virus; Human immunodeficiency virus; human immuno-deficiency viruses; human immunodeficiency viruses

buprenorphine hydrochloride (Probuphine)

Last Updated: June 13, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: buprenorphine hydrochloride
Indications: Opioid drug dependence, treatment

  • Brand Name: Probuphine
  • Manufacturer: Knight Therapeutics Inc.
  • Project Number: SR0550-000
  • Project Status: Active
  • Submission Type: New

Tags

Mental Health, Drug Implants, Opioid-Related Disorders, Addiction, Mental health, Probuphine; buprenorphine hydrochloride